Resp Flashcards

1
Q

Pneumonia: Criteria for hospitalization

A

CURB-65

  • Confusion: abbrev MT 7mmol/L
  • RR > 30
  • BP < 90 systolic

Score 0-1 = home
Score 2 = hospital therapy
Score >2 = severe pneumonia and may require ICU.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Community acquire pneumonia: organisms & empirical treatment

A

Organisms:

  • Streptococcus pneum.
  • Haemophilus Influenza

Treatment for mild:

  • Oral amoxicillin 500mg/8hr OR
  • Clarithromycin 500mg/12hrs

Treatment for moderate:
- IV amoxicillin + clarirthromycin at doses
above.

Treatment of severe case:

  • Co-amoxiclav 1.2g/12hr IV or cefuroxime
    1. 5g/8hrs AND clarithromycin 500mg/12hr IV
  • Add flucloxacillin if Staph suspected.
  • Add vancomycin if MRSA suspected.
  • Treat for 10 days.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hospital acquired pneumonia: Organisms and treatment

A

Organisms

  • Gram negative bacillus
  • Pneudomonas
  • Anaerobes

Treatment:

  • Aminoglycoside IV + pipericillin (anti-
    pseudo) IV. OR
  • 3rd generation cephalosporin IV.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aspiration pneumonia: organisms + treatment

A

Organisms:

  • Streptococcus
  • Anaerobes

Treatment:
- Cefuroxime 1.5g/8hr IV + metronidazole 500mg/8h IV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Differential diagnosis of lung nodule on chest XRY

A
  • Primary or secondary malignancy
  • Abscess
  • Granuloma
  • Carcinoid tumour
  • Pulmonary hamartoma
  • AV fistula
  • Cyst
  • Foreign body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Management of acute asthma attack: According to clinical oxford guidelines

A
  1. Assess the severity of attack
    • ABC’s
    • Can the patient talk/complete
      sentences.
    • Level of consciousness
    • Silent chest
  2. Immediate treatment
    • Sit patient up
    • High dose O2 in 100% non-
      rebreathing bag.
    • Salbutamol 5mg + ipratropium
      bromide 0.5mg nebulized with
      oxygen.
    • Prednisalone 40-50mg IV or
      hydrocortisone 100mg IV.
    • CXR to exclude pneumothorax
  3. Life threating features present
    • Call for senior help
    • Mg 1.2-2mg IV over 2 minutes.
    • Salbutamol 5mg every 15 min => ECG
  4. Patient improving
    • Decrease O2 to 40-60%
    • Pred 40-50mg/24hrs PO for 5 days
    • Neb salbutomol q4hr
    • Monitor peak flow + O2 sats
  5. Patient not improving
    • Continue 100% oxygen
    • Salbutamol every 15 min
    • Continue Ipratropium bromide 0.5mg
      q4-6hrs.
  6. Still not improving
    • Mg if not already given.
    • Consider aminophylline: 5mg/kg IV
      loading; 500ug/kg/hr
    • Adjust according to plasma levels.
    • OR IV Salbutamol 3-20ug/min
    • IPPV
    • ITU
  7. Once patient has improved
    • Wean off aminophylline over 24hrs
    • Switch to inhaled B2 agonist
    • Stop IV steroids; start oral
    • Monitor PEF
    • Look for cause.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Signs of severe asthma attack

A
  • Unable to complete sentences
  • RR > 25
  • Pulse > 110
  • PEF < 50% of predicted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Signs of life threatening attack

A
-  Peak expiratory flow < 33% of predicted 
   or best.
-  Silent chest.
-  Cyanosis
-  Decreased respiratory effort
-  Bradycardia or hypotension
-  Exhaustion, confusion, coma
-  ABG:  PaCO2 > 4.6, PO2 < 8kPa/60mmHg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Salbutamol:

  1. MOA
  2. SE
  3. Method of adminitration
  4. Dose used in asthma
A
  1. Relax bronchial smooth muscle within
    minutes - short acting.
  2. SE: tachyarrhythmias, decreased K+,
    tremor, anxiety.
  3. Aerosol, powder, nebulizer, PO or IV.
  4. Inhaled aerosol 100-200ug/6hrs
    Inhaled powder 200-400ug/6hrs
    Nebulized (supervised) 2.5-5mg/6hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Salmeterol: Dose/puff and regimen

A

Inhaled aerosol
Dose/puff = 25ug
Recommended = 50-100ug/12hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Corticosteroids in asthma

  1. MOA
  2. SE
  3. Doses used in acute vs. long term
A

1 Act over days to decrease bronchial
mucosal inflammation.

  1. Oral candidasis - rise mouth after use
    SE from oral - cushingoid
  2. Oral steroids
    Acute: prednisolong 40mg/24hr po
    Long term: 5-10mg/24hrs poInhaled beclometasone
    Dose/puff = 50ug, 100ug or 250ug
    Recommended = 100ug/12hrs up to
    1000ug/12hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aminophylline

  1. MOA
  2. SE
  3. Indications
A
  1. Metabolized to theophylline
    Inhibits phosphodiesterase = increases
    cAMP = decreases bronchoconstriction
  2. Arrhythmias, GI upset, seizures
  3. Used as an adjunct if inhaled therapy is
    inadequate; given at night PO may
    prevent morning dips; used IV in acute
    severe asthma attacks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ipratropium bromide

  1. MOA
  2. SE
  3. Indications
  4. Dose
A
  1. Anticholinergic - decreases muscle spasm
  2. Not recommended in guidelines for
    asthma
    Used in severe asthma attacks
    More benefit in COPD
4.  Aerosol : Dose/puff = 20ug
                   Regimen 20-40ug/6hr
     Powder:  Dose/puff = 40ug
                   Regimen 40-80ug/6hrs
     Nebulized: Doss/puff = 250ug/mL
                     Regmen = 250-500ug/6hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define asthma

A
  • Obstructive lung disease
  • Characterized by
    1. Airway hypersensitivity,
    2. Reversible airflow obstruction
    3. Inflammation of bronchi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Classification of asthma

A
  1. Intermittent
    • Day time asthma symptoms occur
      less than 2x per week.
    • < 2 nocturnal awakenings per month
    • Use SABA < 2/week
    • No interference with daily activity
    • FEV1 > 80% of predicted normal
    • Normal FEV1/FVC
  2. Mild persistent
    • Symptoms more than twice per week.
    • 3-4 nocturnal wakings per mo
    • SABA use for more than 2x week
    • Minor interference with activities
    • FEV1/FVC normal
    • > 2 exacerbations requiring steroids
      per year.
  3. Moderate persistent
    • Daily symptoms
    • Nocturnal wakings > 1x week
    • Need BA daily
    • Limitation in normal daily activities
    • FEV1 = 60-80%
    • FEV1/FVC < normal
  4. Severe persistent
    • Symptoms of asthma throughout day
    • Nocturnal waking every night
    • Use SABA several times a day
    • Extreme limitations to daily activity
    • FEV1 < 60% of predicted
    • FEV1/FVC < normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Basic principals in managing asthma

A
  1. Lifestyle and triggers
  2. Education on proper technique
  3. Pharmcology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Step wise approach to managing asthma

A
Step 1
-  For intermittent asthma
-  SABA
-  If need SABA more than 2x / week = step 
   up.

Step 2
- Mild persistent asthma
- SABA + low dose glucocorticoid
(<800mcg/day).

Step 3

  • Moderate persistent
  • SABA + inhaled corticosteroids
  • Add long acting B2 agonist
  • +/- leukotriene antagonist (montelukast)
  • +/- aminophylline
Step 4&5
- Severe persistent
- Inhaled glucocorticoids high dose (up to 
  2000mcg/day) + LABA
-  +/- leukotriene antagonist or 
   aminophylline
-  +/- Anti-IgE therapy = omalizumab } 
   consider for patients with allergies.

Step 6
- Below + oral steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Investigations for asthma

A
  • PFT: FEV1/FVC, PEFR
  • Bronchial provocation testing with
    histamine or metacholine.
  • Reversibility testing with B2 agonist }
    FEV1 should increase by 12%.
  • Diurinal varability
  • CXR for hyperinflation
  • CBC = eosinophilia
  • IgE = high
  • RAST test
  • Skin prick test
  • O2 sats = aim > 92%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Asthma: What indicates good control?

A
Well controlled
-  Less than 2 day time symptoms per 
   week.
-  No night time symptoms
-  Normal PEF

Partially controlled
- > 2 symptoms per week

Uncontrolled
- All of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Definition of COPD

A
- Characterized by irreversible airway 
  obstruction.
-  Two subtypes:  chronic bronchitis + 
   emphysema.
-  Characterized by a gradual decline in 
   FEV1 over years.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chronic bronchitis:

  1. Definition
  2. Pathophys
  3. Signs & symptoms
  4. Chest XRY findings
  5. PFT
A
Chronic bronchitis
1. Productive cough on most days for at 
    least 3 consecutive months in 2 
    successive years.
    "Blue bloaters" - decrease alveolar 
     ventilation, hypoxic drive, low PaO2, 
     high PaCO2.
  1. Pathophys: obstruction due to narrowing of the airways lumen by mucosal thickening and excessive mucus production.
  2. Symptoms:
    • Chronic productive cough
    • Purulent sputum
    • Hemoptysis
    • Dyspnea
      Signs:
    • Cyanotic due to hypoexemia and
      hypercapnea.
    • RHF; cor pulmonale
    • Crackles; wheeze
    • Prolonged expiration
  3. Chest XRY: Normal AP diameter, increased bronchovascular markings, enlarged heart with cor pulmonale.
  4. PFT: Decrease FEV1/FVC, Normal TLC, normal Dco2.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Emphsema

  1. Definition & Pathophys
  2. Signs
  3. Symptoms
  4. Chest XRY findings
  5. PFT
A

Emphysema
1. Definition & pathophy:
- Dilation and destruction of air spaces
distal to the terminal bronchioles
without obvious fibrosis.

-  There is decreased elastic recoil => 
   causing air trapping and alveolar 
   collapse.

 -  Pink puffers - increased alveolar 
    ventilation, normal PaO2, normal/low 
    PaCO2.  Breathless but not 
   cyanosed.
  1. Symptoms
    • Dyspnea
    • Minimal cough
    • Tachypnea
    • Decreased exercise tolerance
  2. Signs
    • Pink skin
    • Accessory muscle use
    • Cachetic appearance due to anorexia &
      increased work of breathing.
    • Hyperinflation/barrel chest
    • Hyperressonant percussion note
    • Decreased breath sounds
    • Decreased diaphargmatic excursion.
  3. Chest XRY
    • Increased AP diameter
    • Flat hemidiaphragm = 6 ribs anteriorly
    • Decreased heart shadow
    • Bullae
    • Decreased vascular markings.
  4. PFTs
    • Decrease FEB1/FVC
    • Increase TLV = hyperinflation
    • Increase RV = gas trapping
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Severity / Stages of COPD

A

FEV1 determines severity

  1. Stage I - Mild symptoms
    - FEV1/FVC < 70%
    - FEV1 > 80%
  2. Stage II - Moderate COPD
    - Symptoms on exertion
    - FEV1/FVC < 70%
    - FEV1 = 50-80%
  3. Stage III - Severe COPD
    - Symptoms on minimal
    exertion
    - FEV1/FVC < 70%
    - FEV1 30-50%
  4. Stage IV - Very severe COPD
    - Symptoms at rest
    - FEV1 < 30%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatment of COPD based on severity

A

Stage I - Mild

  • Stop smoking, influenza vaccine.
  • Inhaled ipratropium bromide preferred prn
  • Inhaled SABA prn

Stage II - Moderate

  • As above
  • Regular ipratropium bromide OR
  • Long acting B2 agonist

Stage III - Severe
- As above + add in inhaled steroids.

Stage IV - Very severe
- Long term home oxygen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Indications for home oxygen therapy
- PaO2 < 7.2 kPa - Clinically stable non smoker - PaO2 7.3-8 and pulmonary HTN + cor pulm - Terminally ill patient
26
Acute exacerbation of COPD 1. Definition 2. Management
Acute exacerbation of COPD 1. Increased breathlessness, increased sputum production. 2. Managment - ABC - O2 24-28% - Aim for: PaO2 > 8kPa with rise in PaCO2 not greater than 1.5kPa. - Nebulized salbutamol 5mg/4hr + impratropium bromide 500ug/6hrs - Steroids: IV hydrocort 200mg + PO prednisolone 30-40mg Continue for 7-14 days - Antibiotics if infection suspected Amoxicillin 500mg/8hr PO - Physio: sputum expectoriation - Not responding: Repeat nebulizer Consider aminophylline - NR: Consider nasal PPV if RR > 30 - NR: Consider intubation/ventilation if CO2 rising.
27
Bronchiectasis 1. Definition 2. Signs and symptoms 3. Findings: PFT & Chest XRY 3. Principals in treatment
1. Definition - Irreversible dilatation of airways due to inflammation and destruction of airway walls from persistently infected mucus. - Usually medium to small sized airways effected. 2. Signs and symptoms - Chronic cough - Purulent sputum - Hemoptysis *massive* - Recurrent pneumonia - Local crackles = inspir + expir - Wheeze - Clubbing - Difficult to differentiate from chronic bronchitis 3. Findings on investigation - PFT: Obstructive pattern - XRY: Linear atelectasis, loss of volume, honeycomb structures 4. Treatment - Vaccination: influenza & pneumovax - Antibiotics - Inhaled steroids - Oral steroids for acute exacerbations - Chest physio - Pulmonary resection if necessary
28
Definitions 1. Hypoexemic 2. Hypercapnic
1. Hypoxemic - PaO2 < 60mmHg - PaO2 < 8kPa 2. Hypercapnic - PaCO2 > 50mmHg - PaCO2 > 6kPa
29
Signs of hypoxemia
- Dyspnea - Restlessness - Agitation - Confusion - Central cyanosis - Polycythemia - Pulmonary hypertension - Cor pulmonale
30
Signs of hypercapnia
- Headache - Dyspnea - Drowsiness - Asteixis / flapping tremor - Warm peripheries - Plethora - Raised ICP - Tachycardia - Bounding pulses
31
Causes of hypoxemia
1. Low FiO2 = high altitude 2. Hypoventilation 3. Shunting 4. Low mixed venous O2 content 5. V/Q mismatch
32
Causes of hypercarbia
1. High inspired CO2 2. Low total ventilation 3. High deadspace ventilation 4. High CO2 production - fever, sepsis
33
Target O2 sat in COPD patients
COPD patients: Goal SaO2 88-92% | Everyone else: Goal SaO2 94-98%
34
Type I respiratory failure: 1. Definition 2. Cause 3. Treatment
1. Definition: - Hypoxia: PaO2 < 8kPa - Normal or low PaCO2 2. Cause - V/Q mismatch: asthma, COPD, pulmonary edema, PE - Shunt: alvelar collapse, intracardiac shunt, intrapulmonary shut = AVM - Low inspired O2: High altitude 3. Treatment - Reverse pathology / underlying cause - Maintain oxygenation - Increase FiO2 **Supplementing O2 won't work if shunting is the problem** - PEEF/CPAP: to recruit alveoli
35
Type II respiratory failure 1. Definition 2. Cause 3. Treatment
1. Definition - PaCO2 increased = hypercapnia - PaO2 decreased = hypoxia 2. Causes: - Increased CO2 production: fever, sepsis - Alveolar hypoventilation: COPD, asthma, chest wall disorder, CF. - Hypoventilation: Central = stroke Drugs = opiates, benzo NMJ = GB, MG, fatigue 3. Treatment - Find and fix cause - Same as above - maintain oxygenation, mechanical ventilation if necessary.
36
Differential diagnosis of hemoptysis
``` Resp causes: - Infectious: TB, lung abscess - Airway disease: COPD, chronic bronchitis, bronchiectasis. - Pulm vasc disease: PHTN, vasculitis, PE - Parencymal disease: pneumonia, wegener's, goodpastures - Malignancy ``` Cardiac causes: - MI - CHF - MS Hem: - Anemia - Coagulopathy
37
Definition of finger clubbing
Loss of the angle between the nail and nail fold. The nail fold feels boggy.
38
Causes of finger clubbing
Respiratory causes: - Lung ca, mesothelioma - Chronic lung infection: bronchiectasis, TB, empyema, abscess, cystic fibrosis. GI: - IBD (especially Crohn's) - Malabsorption = celiac - GI lymphoma - Cirrhosis Cardiac: - Cyanotic heart disease - Endocarditis - Atrial myxoma - Aneurysms Other: - Thyroid acropachy - Esophageal Ca.
39
Normal values:pH, PaO2, PaCO2, HCO3
pH: 7.35-7.45 PaCO2: 4.7-6kPa ; 35-45mmHg PaO2: >10.6kPa ; 75-100mmHg HCO3: 24mEq/L
40
Anion gap: Formula and when to calculate
If there is a metabolic acidosis - calculate the anion and osmolar gap. AG: Na - [(CL + HCO3)] = 10-15 mmol/L If the anion gap is increased - is the change in the AG the same as the change in bicarbonate? If no = mixed picture. Osmolar gap = measure - calculated osmolarity = (2[Na] + glucose + urea) = normal 10
41
Differential diagnosis of respiratory acidosis
**Characterized by increased PCO2 secondary to hypoventilation ** ``` Resp center depression - Stroke - Drugs: opiates, sedatives, anesthesia - Raised ICP - Encephalitis - Central apnea - Supplemental O2 in CO2 retainers (COPD) ``` Neuromuscular disorders - MG - GB - Poliomyositis - Muscular dystrophies - ALS ``` Lung disease - Airway obstruction: asthma, COPD, foreign body - Parenchymal disease: pneumonia, pneumothorax, pulm edema, ARDS ``` Other: - Inadequate mechanical ventilation
42
Differential diagnosis of respiratory alkalosis
**Characterized by decreased PaCO2 secondary to hyperventilation** Hypoxemia - Pneumonia, PE, edema - Severe anemia - Heart failure - High altitude Resp center stimulation - CNS disorders - Hepatic failure - Drugs: stimulants, ASA, catecholamines - Pregnancy - Anxiety - Pain Other cause: - Mechanical hyperventilation
43
Causes of anion gap metabolic acidosis
``` MUDPILES Methanol Uremia DKA/starvation/alcoholic Paraldehyde Isopropyl alcohol/Iron/INH Lactic acidosis Ethylene glycol Salicylates ```
44
Causes of non-anion gap metabolic acidosis
``` HARDUP Hyperailmentation Acetazolamide RTA** Ureteroenteric fistual Pancreaticoduodenal fistula increased ```
45
Causes of metabolic alkalosis
- Vomiting = loss GI H+ - Exogenous alkali syndrome - Milk alkali syndrome - Diuretics = contraction alkalosis - Post hypercapnea - Hyperaldosterisms - Hypokalemia
46
Interstitial lung disease 1. Pathophy 2. Causes of ILD by lung field effects
1. Pathophy - Inflammatory process in the alveoli that results in thickening, destruction and fibrosis. - Restrictive lung disease - Decreased lung compliance & lung volumes. 2. Upper lung disease - Farmers lung - Ankylosing spondylitis - Sarcoidosis - Silicosis - TB - Neurofibromatosis ``` Lower lung disease - Asbestosis - Drugs: nitrofurantoin, amiodarone, chemo - Rhematological disease - Scleroderma ```
47
Interstitial lung disease: Cause based on known and unknown etiology
Unknown etiology - Idiopathic pulmonary fibrosis - Sarcoidosis - Histocytosis X ``` ILD associated with known systemic disease Rheumatological - Scleroderma - Rhematoid arthritis - SLE - Mixed CTD ``` Enviro/occupational - Farmers lung - Bird lung - Air conditioners - Silicosis - Asbestosis - Coal workers pneumoconiosis - Berylliosis Drugs - Nitrofurantoi - Methotrexate - amiodarone - Chemotherapy - Ampetamines - Radiation Pulm vasclitis - Wegeners - Churg strauss - Hypersensitivity reaction Inherited disorders - Neurofibromatosis - Tuberous sclerosis - Gauchers disease
48
Clinical features of interstitial lung disease
- Dyspnea on exertion - Non productive cough - Abnormal breath sounds - Fine end inspiratory crepitations **PF** - Weight loss - Arthralagia (depending on type) - Restrictive pattern on PFTs - Decreased DL due to loss of SA for gas exchange.
49
Pleural effusions: 1. Lights criteria: transudate vs exudate 2. Cause of transudate 3. Cause of exudate
``` 1. Lights criteria Transudate: Protein [P/S] < 0.5 LDH [P/S] < 0.6 Pleural LDH < 2/3 upper limit of N serum LDH ``` Exudate Protein [P/S] > 0.5 LDH [P/S] > 0.6 Pleural LDH > 2/3 upper limit of N serum LDH 2. Cause of transudate - CHF - Cirrhosis - Nephrotic syndrome - Pulmonary embolism - Hypothryoidism 3. Causes of exudate - Infectious: pneumonia, parapneumonic effusion, empyema. - Malignancy - Inflammatory: collagen vascular disorder, RA, SLE, pulmonary embolism - Intra-abdo: Meigs syndrome, pancreatitis, esophageal rupture. - Trauma
50
Pleural fluid analysis: Protein, glucose, pH, cytology
Protein content - < 30g/L = transudate - > 30g/L = exudate - Between 25-35g/L use Lights criteria Glucose content - < 3.3 mmol/L = malignancy, TB, RA pH < 7.2 = infection or malignancy, requires drainage. ``` Cell types - Neutrophilia = infection - Lymphocytes = TB, lymphoma, malignancy - RBC = trauma, cancer, lymphoma ```
51
Classification of pleura effusion: simple vs complication
Simple effusion: pH > 7.2, LDH < 1/2 serum, glucose > 2.2 Complicated pH < 7.2, LDH > 1/2 serum, glucose < 2.2, positive gram stain = needs drainage
52
Differential diagnosis of solitary pulmonary nodule
Nodule is defined as being < 3cm Mass > 3cm - Infectious granuloma - Abscess - Aspergilloma - Hamartoma - Bronchiogenic cyst - Fibroma - AVM - Rheumatoid nodule - Sarcoidosis - Primary lung ca - Secondary lung ca - Pulmonary carcinoid
53
Features of benign vs. malignant pulmonary nodule
Benign pulmonary nodule - < 3cm, round, regular - Smooth - Calcified pattern - Doubles in > 2 years Malignant pulmonary nodule - >3cm, irregular, spiculated - Ill defined or noticed - NOT calcified - Doubles in < 1 month or < 2 years.
54
Paraneoplastic syndrome associated with small cell carcinoma of lung "oat cell"
- ACTH = cushing - SIADH - Eaton Lambert
55
Paraneoplastic syndrome associated with NSC lung cancer
Squamous cell carcinoma | PTH-related peptide = hypercalcemia + hypophosphatemia
56
Pleural effusions: amount of fluid required before it can be detected clinically
500mL
57
Signs and symptoms of PE
Symptoms: - Acute breathlessness - Pleuritic chest pain - Hemoptysis - Dizziness - Collapse Signs: - Pyrexia - Tachycardia - Tachpnea - Hypotension - Raised JVP - Pleural rub - Pleural effusion
58
Wells score for investigating a suspected DVT
Risk factors - Active cancer (1) - Paralysis/immobility (1) - Major surgery (1) Clinical signs - Tenderness along leg (1) - Entire leg swollen (1) - Calf circumference > 3cm (1) - Pitting edema (1) - Collateral superficial veins visible (1) Other: - Alternative as likely or more likely than DVT (-2)
59
Investigation of PE
- CXR - ABG: decreased PaO2 and PaCO2 - ECG: S1Q3T3 pattern - D-dimers: High sen, low spec Can exclude PE if normal in low risk patient. - CTPA: Sen & spec; First line - V/Q scan: If CXR normal and no lung disease. - Bilateral venograms
60
Management of Pulmonary Embolus
- Give 100% oxygen - Morphine 10mg for pain relief - If critically ill with passive PE consider immediate thrombolysis (50mg Alteplase) - IV access - SC LMWH: Dalteparin 200U/kg o.d Enoxaparin 1mg/kg bid No lab monitoring Avoid in renal failure - UF Heparin IV: 10,000U bolus Then 18U/kg/h guided by aPTT - Systolic BP: > 90 = Warfarin 10mg od < 90 = 500mL colloid Dobutamine 2.5- 10ug/kg/min - Continue warfarin and heparin for 5 days or until INR 2-3.
61
Duration of anti-coagulation following PE
- If reversible cause = 3-6 mo - PE unprovoked = 6mo to indefinite - Ongoing risk present = indefinite